Back to Treatments

Treatment

Rifaximin

1
Conditions
24
Trials
9,000
Participants
70%
Average Safety

Condition Evidence

Irritable Bowel Syndrome

24 trials · 9,000 participants

65% effectiveness · 70% safety
Rifaximin | DFDA